Insider tradingForm 4

Revolution Medicines, Inc. (RVMD) Insider Trading

20 open-market trades reported since Aug 25, 2026: 0 purchases worth $0 and 20 sales worth $78.0M.

By insider

Insider	Role	Bought	Sells	Sold	Latest
Alan B. Sandler	Chief Development Officer	$0	2	$1.34M	Oct 1, 2026
Jeff Cislini	General Counsel	$0	3	$12.7M	Sep 29, 2026
Anthony Mancini	See Remarks	$0	5	$4.60M	Sep 28, 2026
Elizabeth M. Anderson	Director	$0	1	$1.96M	Sep 24, 2026
Mark A. Goldsmith	See Remarks	$0	3	$20.8M	Sep 18, 2026
Stephen Michael Kelsey	See Remarks	$0	2	$19.8M	Sep 18, 2026
Margaret A. Horn	COO	$0	1	$990K	Sep 18, 2026
Jack Anders	CFO	$0	1	$808K	Sep 18, 2026
Lorence H. Kim	Director	$0	2	$15.0M	Sep 10, 2026

All trades

RVMD insider trades
Filed	Traded	Insider	Role	Type	Shares	Price ($)	Value	Holding	Filing
Oct 1	Sep 29	Alan B. SandlerChief Development Officer	Chief Development Officer	▼ SELL10b5-1	6,309	202.14	$1.28M	−11%	Form 4 ↗
Sep 29	Sep 25	Jeff CisliniGeneral Counsel	General Counsel	▼ SELL10b5-1	765	207.32	$159K	−1.5%	Form 4 ↗
Sep 28	Sep 25	Anthony ManciniSee Remarks	See Remarks	▼ SELL10b5-1	3,121	200.54	$626K	−7.3%	Form 4 ↗
Sep 28	Sep 24	Anthony ManciniSee Remarks	See Remarks	▼ SELL10b5-1	587	200.00	$117K	−1.5%	Form 4 ↗
Sep 24	Sep 22	Elizabeth M. AndersonDirector	Director	▼ SELL10b5-1	10,143	193.04	$1.96M	−70%	Form 4 ↗
Sep 22	Sep 18	Anthony ManciniSee Remarks	See Remarks	▼ SELL10b5-1	1,764	196.94	$347K	−4.2%	Form 4 ↗
Sep 18	Sep 16	Mark A. GoldsmithSee Remarks	See Remarks	▼ SELL10b5-1	13,988	199.24	$2.79M	−5.2%	Form 4 ↗
Sep 18	Sep 16	Stephen Michael KelseySee Remarks	See Remarks	▼ SELL10b5-1	5,569	199.24	$1.11M	−1.9%	Form 4 ↗
Sep 18	Sep 16	Margaret A. HornCOO	COO	▼ SELL10b5-1	4,967	199.24	$990K	−3.2%	Form 4 ↗
Sep 18	Sep 16	Jack AndersCFO	CFO	▼ SELL10b5-1	4,053	199.24	$808K	−3.3%	Form 4 ↗
Sep 18	Sep 16	Jeff CisliniGeneral Counsel	General Counsel	▼ SELL10b5-1	3,366	199.24	$671K	−6.0%	Form 4 ↗
Sep 18	Sep 16	Anthony ManciniSee Remarks	See Remarks	▼ SELL10b5-1	1,774	199.24	$353K	−4.0%	Form 4 ↗
Sep 18	Sep 16	Alan B. SandlerChief Development Officer	Chief Development Officer	▼ SELL10b5-1	341	199.24	$68K	−0.6%	Form 4 ↗
Sep 15	Sep 11	Stephen Michael KelseySee Remarks	See Remarks	▼ SELL10b5-1	92,531	202.36	$18.7M	−24%	Form 4 ↗
Sep 14	Sep 10	Anthony ManciniSee Remarks	See Remarks	▼ SELL10b5-1	15,448	204.16	$3.15M	−26%	Form 4 ↗
Sep 10	Sep 8	Lorence H. KimDirector	Director (ind.)	▼ SELL10b5-1	17,090	209.82	$3.59M	All sold	Form 4 ↗
Sep 2	Aug 31	Lorence H. KimDirector	Director (ind.)	▼ SELL10b5-1	56,000	203.24	$11.4M	−77%	Form 4 ↗
Aug 25	Aug 21	Mark A. GoldsmithSee Remarks	See Remarks	▼ SELL10b5-1	80,000	209.20	$16.7M	−23%	Form 4 ↗
Aug 25	Aug 21	Jeff CisliniGeneral Counsel	General Counsel	▼ SELL10b5-1	56,894	209.24	$11.9M	−50%	Form 4 ↗
Aug 25	Aug 21	Mark A. GoldsmithSee Remarks	See Remarks (ind.)	▼ SELL10b5-1	6,000	209.20	$1.26M	−8.8%	Form 4 ↗

Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings